STRUCTURAL HETEROGENEITY OF CAUCASIAN N-ACETYLTRANSFERASE AT THE NAT1 GENE LOCUS

被引:152
作者
VATSIS, KP
WEBER, WW
机构
[1] Department of Pharmacology, Medical School, The University of Michigan, Ann Arbor
关键词
D O I
10.1006/abbi.1993.1116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human N-acetylation polymorphism is a genetic trait phenotypically reflected by differences in N-acetyltransferase (NAT) activity with therapeutic agents (rapid and slow acetylation), but a genetic invariability in N-acetylation of some arylamine drugs is also known. There are two highly similar human NAT genes: NAT1 is thought to encode a genetically invariant protein, whereas NAT2 has conclusively been shown to represent a polymorphic locus. This study demonstrates the presence of discrete NAT1 structural variants among Caucasians. These were detected by direct sequencing of 1.6-kilobase NAT1 fragments generated by the polymerase chain reaction with liver and leukocyte DNA from 13 subjects of established acetylator phenotype and NAT2 genotype. A prominent alteration in one of the variants was obliteration of the consensus polyadenylation signal (AATAAA→AAAAAA). Several mutations were discernible in all regions of the second variant allele, including silent (codon 153) and nonsilent (Ser-214→Ala) substitutions in the coding region and deletion of nine bases from an AT-rich segment in the 3′ untranslated region. One-half of the unrelated subjects were either homozygous or heterozygous for the mutant NAT1 alleles, both of which obeyed a Mendelian inheritance pattern. These novel results unambiguously show that human NAT1, like NAT2, is a polymorphic locus. © 1993 Academic Press, Inc.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 23 条
[1]   POLY(A), POLY(A) BINDING-PROTEIN AND THE REGULATION OF MESSENGER-RNA STABILITY [J].
BERNSTEIN, P ;
ROSS, J .
TRENDS IN BIOCHEMICAL SCIENCES, 1989, 14 (09) :373-377
[2]   MOLECULAR MECHANISM OF SLOW ACETYLATION OF DRUGS AND CARCINOGENS IN HUMANS [J].
BLUM, M ;
DEMIERRE, A ;
GRANT, DM ;
HEIM, M ;
MEYER, UA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) :5237-5241
[3]   HUMAN ARYLAMINE N-ACETYLTRANSFERASE GENES - ISOLATION, CHROMOSOMAL LOCALIZATION, AND FUNCTIONAL EXPRESSION [J].
BLUM, M ;
GRANT, DM ;
MCBRIDE, W ;
HEIM, M ;
MEYER, UA .
DNA AND CELL BIOLOGY, 1990, 9 (03) :193-203
[4]  
CRIBB AE, 1991, J PHARMACOL EXP THER, V259, P1241
[5]  
DEGUCHI T, 1990, J BIOL CHEM, V265, P12757
[6]   STRUCTURE AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF GENES FOR HUMAN LIVER ARYLAMINE N-ACETYLTRANSFERASES [J].
EBISAWA, T ;
DEGUCHI, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 177 (03) :1252-1257
[7]  
EVANS DAP, 1989, PHARMACOL THERAPEUT, V42, P157
[8]   PHARMACOGENETICS [J].
EVANS, DAP .
AMERICAN JOURNAL OF MEDICINE, 1963, 34 (05) :639-+
[9]  
GRANT DM, 1991, MOL PHARMACOL, V39, P184
[10]   A BEGINNING TO THE BIOCHEMISTRY OF POLYADENYLATION [J].
HUMPHREY, T ;
PROUDFOOT, NJ .
TRENDS IN GENETICS, 1988, 4 (09) :243-245